{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:19:50Z","timestamp":1783606790788,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2023A1515010253"],"award-info":[{"award-number":["2023A1515010253"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04317-z","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T06:26:59Z","timestamp":1777098419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insulin-like growth factor-binding protein 5 promotes prostate cancer metastasis and osteoblastic activity by inducing chemokines and activating NF-\u03baB signaling"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhongqin","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changmin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongwei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.urology.2015.12.039","volume":"92","author":"J Hensel","year":"2016","unstructured":"Hensel J, Thalmann GN. Biology of Bone Metastases in Prostate Cancer. Urology. 2016;92:6\u201313. https:\/\/doi.org\/10.1016\/j.urology.2015.12.039.","journal-title":"Urology"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s44197-023-00103-6","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang W, Cao G, Wu F, Wang Y, Liu Z, Hu H, Xu K. Global burden of prostate cancer and association with socioeconomic status, 1990\u20132019: a systematic analysis from the global burden of disease study. J Epidemiol Global Health. 2023;13:407\u201321.","journal-title":"J Epidemiol Global Health"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","volume":"8","author":"J Sturge","year":"2011","unstructured":"Sturge J, Caley MP, Waxman J. Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Reviews Clin Oncol. 2011;8:357.","journal-title":"Nat Reviews Clin Oncol"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/PAP.0000000000000422","volume":"31","author":"D Akhoundova","year":"2024","unstructured":"Akhoundova D, Francica P, Rottenberg S, Rubin MA. DNA damage response and mismatch repair gene defects in advanced and metastatic prostate cancer. Adv Anat Pathol. 2024;31:61\u20139.","journal-title":"Adv Anat Pathol"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3389\/fonc.2019.00801","volume":"9","author":"MA Rice","year":"2019","unstructured":"Rice MA, Malhotra SV, Stoyanova T. Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer. Front Oncol. 2019;9:801.","journal-title":"Front Oncol"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.5534\/wjmh.220200","volume":"41","author":"K Hatano","year":"2023","unstructured":"Hatano K, Nonomura N. Systemic therapies for metastatic castration-resistant prostate cancer: an updated review. World J Men\u2019s Health. 2023;41:769.","journal-title":"World J Men\u2019s Health"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41419-022-05084-1","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhou Q, Hankey W, Fang X, Yuan F. Second generation androgen receptor antagonists and challenges in prostate cancer treatment. Cell Death Dis. 2022;13:632.","journal-title":"Cell Death Dis"},{"key":"4317_CR8","doi-asserted-by":"crossref","unstructured":"Boudadi K, Antonarakis ES. Resistance to novel antiandrogen therapies in metastatic castration-resistant prostate cancer. Clin Med Insights: Oncol. 2016;10(Suppl 1):1-9.","DOI":"10.4137\/CMO.Ss34534"},{"key":"4317_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","volume":"18","author":"KT Schmidt","year":"2021","unstructured":"Schmidt KT, Huitema AD, Chau CH, Figg WD. Resistance to second-generation androgen receptor antagonists in prostate cancer. Nat Reviews Urol. 2021;18:209\u201326.","journal-title":"Nat Reviews Urol"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20060086","volume":"395","author":"J Beattie","year":"2006","unstructured":"Beattie J, Allan GJ, Lochrie JD, Flint DJ. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J. 2006;395:1\u201319.","journal-title":"Biochem J"},{"key":"4317_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fendo.2020.00100","volume":"11","author":"C Duan","year":"2020","unstructured":"Duan C, Allard JB. Insulin-like growth factor binding protein-5 in physiology and disease. Front Endocrinol. 2020;11:100.","journal-title":"Front Endocrinol"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/01.RES.0000124761.62846.DF","volume":"94","author":"Q Xu","year":"2004","unstructured":"Xu Q, Li S, Zhao Y, Maures TJ, Yin P, Duan C. Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells. Circul Res. 2004;94:e46\u201354. https:\/\/doi.org\/10.1161\/01.RES.0000124761.62846.DF.","journal-title":"Circul Res"},{"key":"4317_CR13","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/endo.140.5.6702","volume":"140","author":"CW Gregory","year":"1999","unstructured":"Gregory CW, Kim D, Ye P, D\u2019Ercole AJ, Pretlow TG, Mohler JL, French FS. Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft*. Endocrinology. 1999;140:2372\u201381. https:\/\/doi.org\/10.1210\/endo.140.5.6702.","journal-title":"Endocrinology"},{"key":"4317_CR14","first-page":"3058","volume":"60","author":"H Miyake","year":"2000","unstructured":"Miyake H, Pollak M, Gleave ME. Castration-induced Up-Regulation of Insulin-like Growth Factor Binding Protein-5 Potentiates Insulin-like Growth Factor-I Activity and Accelerates Progression to Androgen Independence in Prostate Cancer Models1. Cancer Res. 2000;60:3058\u201364.","journal-title":"Cancer Res"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/his.12662","volume":"67","author":"E Specht","year":"2015","unstructured":"Specht E, Kaemmerer D, S\u00e4nger J, Wirtz RM, Schulz S, Lupp A. Comparison of immunoreactive score, HER2\/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology. 2015;67:368\u201377.","journal-title":"Histopathology"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","volume":"41","author":"H Liu","year":"2023","unstructured":"Liu H, Zhao Q, Tan L, Wu X, Huang R, Zuo Y, Chen L, Yang J, Zhang Z-X, Ruan W. Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma. Cancer Cell. 2023;41:693\u2013710.","journal-title":"Cancer Cell"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/1535-7163.MCT-16-0124","volume":"16","author":"K-Y Teng","year":"2017","unstructured":"Teng K-Y, Han J, Zhang X, Hsu S-H, He S, Wani NA, Barajas JM, Snyder LA, Frankel WL, Caligiuri MA. Blocking the CCL2\u2013CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model. Mol Cancer Ther. 2017;16:312\u201322.","journal-title":"Mol Cancer Ther"},{"key":"4317_CR18","doi-asserted-by":"crossref","unstructured":"Dakal T.C., Bhushan R., Xu C., Gadi B.R., Cameotra S.S., Yadav V., Maciaczyk J., Schmidt-Wolf I.G., Kumar A., Sharma A. Intricate relationship between cancer stemness, metastasis, and drug resistance. MedComm. 2024;5(10):e710.","DOI":"10.1002\/mco2.710"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/onc.2013.191","volume":"33","author":"G Comito","year":"2014","unstructured":"Comito G, Giannoni E, Segura C, Barcellos-de-Souza P, Raspollini M, Baroni G, Lanciotti M, Serni S, Chiarugi P. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014;33:2423\u201331.","journal-title":"Oncogene"},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","volume":"4","author":"S Heerboth","year":"2015","unstructured":"Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S. EMT and tumor metastasis. Clin Translational Med. 2015;4:6.","journal-title":"Clin Translational Med"},{"key":"4317_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11914-018-0480-6","volume":"16","author":"S-C Lin","year":"2018","unstructured":"Lin S-C, Yu-Lee L-Y, Lin S-H. Osteoblastic factors in prostate cancer bone metastasis. Curr Osteoporos Rep. 2018;16:642\u20137.","journal-title":"Curr Osteoporos Rep"},{"key":"4317_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.urology.2015.12.039","volume":"92","author":"J Hensel","year":"2016","unstructured":"Hensel J, Thalmann GN. Biology of bone metastases in prostate cancer. Urology. 2016;92:6\u201313.","journal-title":"Urology"},{"key":"4317_CR23","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/s41388-019-0873-8","volume":"38","author":"L Li","year":"2019","unstructured":"Li L, Ameri AH, Wang S, Jansson KH, Casey OM, Yang Q, Beshiri ML, Fang L, Lake RG, Agarwal S. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene. 2019;38:6241\u201355.","journal-title":"Oncogene"},{"key":"4317_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11914-024-00897-9","volume":"23","author":"Y Shiozawa","year":"2025","unstructured":"Shiozawa Y, Parajuli KR, Pienta K, Taichman R. Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis. Curr Osteoporos Rep. 2025;23:3.","journal-title":"Curr Osteoporos Rep"},{"key":"4317_CR25","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/1878-0261.12327","volume":"12","author":"B Cioni","year":"2018","unstructured":"Cioni B, Nevedomskaya E, Melis MH, van Burgsteden J, Stelloo S, Hodel E, Spinozzi D, de Jong J, van der Poel H, de Boer JP. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2\u2010and CXCL8\u2010mediated cancer cell migration. Mol Oncol. 2018;12:1308\u201323.","journal-title":"Mol Oncol"},{"key":"4317_CR26","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/s41598-020-62416-x","volume":"10","author":"TM Pausch","year":"2020","unstructured":"Pausch TM, Aue E, Wirsik NM, Freire Valls A, Shen Y, Radhakrishnan P, Hackert T, Schneider M, Schmidt T. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Sci Rep. 2020;10:5420.","journal-title":"Sci Rep"},{"key":"4317_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13105-023-00944-6","volume":"79","author":"B Fang","year":"2023","unstructured":"Fang B, Wang X, Sun Y, Xiong X, Meng X, Li W, Yi Z. Hypoxia-induced CCL2\/CCR2 axis in adipose-derived stem cells (ADSCs) promotes angiogenesis by human dermal microvascular endothelial cells (HDMECs) in flap tissues. J Physiol Biochem. 2023;79:327\u201339.","journal-title":"J Physiol Biochem"},{"key":"4317_CR28","doi-asserted-by":"publisher","first-page":"22880","DOI":"10.18632\/oncotarget.4412","volume":"6","author":"X-P Li","year":"2015","unstructured":"Li X-P, Yang X-Y, Biskup E, Zhou J, Li H-L, Wu Y-F, Chen M-L, Xu F. Co-expression of CXCL8 and HIF-1\u03b1 is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget. 2015;6:22880.","journal-title":"Oncotarget"},{"key":"4317_CR29","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1210\/endo.140.5.6702","volume":"140","author":"CW Gregory","year":"1999","unstructured":"Gregory CW, Kim D, Ye P, D\u2019Ercole AJ, Pretlow TG, Mohler JL, French FS. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology. 1999;140:2372\u201381.","journal-title":"Endocrinology"},{"key":"4317_CR30","doi-asserted-by":"crossref","unstructured":"Chen X, Yu Q, Pan H, Li P, Wang X, Fu S. Overexpression of IGFBP5 enhances radiosensitivity through PI3K-AKT pathway in prostate cancer. Cancer Manage Res. 2020;12:5409-5418.","DOI":"10.2147\/CMAR.S257701"},{"key":"4317_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13073-020-00776-9","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin W, Noel P, Borazanci EH, Lee J, Amini A, Han IW, Heo JS, Jameson GS, Fraser C. Steinbach, others, Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Med. 2020;12:80.","journal-title":"Genome Med"},{"key":"4317_CR32","doi-asserted-by":"publisher","first-page":"104119","DOI":"10.1016\/j.cellimm.2020.104119","volume":"353","author":"L-Q Fu","year":"2020","unstructured":"Fu L-Q, Du W-L, Cai M-H, Yao J-Y, Zhao Y-Y, Mou X-Z. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353:104119.","journal-title":"Cell Immunol"},{"key":"4317_CR33","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","volume":"65","author":"CL Hall","year":"2005","unstructured":"Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 2005;65:7554\u201360.","journal-title":"Cancer Res"},{"key":"4317_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12974-017-0820-y","volume":"14","author":"J Lechner","year":"2017","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, Xu H. Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8). J Neuroinflamm. 2017;14:42.","journal-title":"J Neuroinflamm"},{"key":"4317_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10555-021-09974-2","volume":"40","author":"\u00c9 Midavaine","year":"2021","unstructured":"Midavaine \u00c9, C\u00f4t\u00e9 J, Sarret P. The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers. Cancer Metastasis Rev. 2021;40:427\u201345.","journal-title":"Cancer Metastasis Rev"},{"key":"4317_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","volume":"21","author":"A Oh","year":"2023","unstructured":"Oh A, Pardo M, Rodriguez A, Yu C, Nguyen L, Liang O, Chorzalska A, Dubielecka PM. NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype. Cell Communication Signal. 2023;21:291.","journal-title":"Cell Communication Signal"},{"key":"4317_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00109-022-02179-2","volume":"100","author":"R Xu","year":"2022","unstructured":"Xu R, Liu X, Li A, Song L, Liang J, Gao J, Tang X. c-Met up-regulates the expression of PD-L1 through MAPK\/NF-\u03baBp65 pathway. J Mol Med. 2022;100:585\u201398.","journal-title":"J Mol Med"},{"key":"4317_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neo.2017.02.002","volume":"19","author":"JJ Nunes","year":"2017","unstructured":"Nunes JJ, Pandey SK, Yadav A, Goel S, Ateeq B. Targeting NF-kappa B signaling by artesunate restores sensitivity of castrate-resistant prostate cancer cells to antiandrogens. Neoplasia. 2017;19:333\u201345.","journal-title":"Neoplasia"},{"key":"4317_CR39","doi-asserted-by":"publisher","first-page":"107538","DOI":"10.1016\/j.pharmthera.2020.107538","volume":"211","author":"SE Thomas-Jardin","year":"2020","unstructured":"Thomas-Jardin SE, Dahl H, Nawas AF, Bautista M, Delk NA. NF-\u03baB signaling promotes castration-resistant prostate cancer initiation and progression. Pharmacol Ther. 2020;211:107538.","journal-title":"Pharmacol Ther"},{"key":"4317_CR40","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1245\/s10434-020-09371-z","volume":"28","author":"F Tang","year":"2020","unstructured":"Tang F, Tie Y, Hong W, Wei Y, Tu C, Wei X. Targeting myeloid-derived suppressor cells for premetastatic niche disruption after tumor resection. Ann Surg Oncol. 2020;28:4030.","journal-title":"Ann Surg Oncol"},{"key":"4317_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10456-024-09913-z","volume":"27","author":"F Yang","year":"2024","unstructured":"Yang F, Lee G, Fan Y. Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism. Angiogenesis. 2024;27:333\u201349.","journal-title":"Angiogenesis"},{"key":"4317_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1513\/pats.201101-009MW","volume":"8","author":"A Rahman","year":"2011","unstructured":"Rahman A, Fazal F. Blocking NF-\u03baB: an inflammatory issue. Proc Am Thorac Soc. 2011;8:497\u2013503.","journal-title":"Proc Am Thorac Soc"},{"key":"4317_CR43","doi-asserted-by":"publisher","unstructured":"Waters JA, Urbano I, Robinson M, House CD. Insulin-like growth factor binding protein 5: Diverse roles in cancer. Front Oncol Volume. 2022;12\u20132022. https:\/\/doi.org\/10.3389\/fonc.2022.1052457.","DOI":"10.3389\/fonc.2022.1052457"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04317-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:22:39Z","timestamp":1781050959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04317-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04317-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human studies were approved by Yuebei peoples hospital of clinical research ethics committee, which is accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All procedures of mouse experiments were approved by the animal ethics committee of Shantou University (SUMC2022-419).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}